Literature DB >> 30826177

Endogenous double-stranded Alu RNA elements stimulate IFN-responses in relapsing remitting multiple sclerosis.

Maxwell J Heinrich1, Caroline A Purcell1, Andrea J Pruijssers2, Yang Zhao3, Charles F Spurlock1, Subramaniam Sriram4, Kristen M Ogden2, Terence S Dermody5, Matthew B Scholz6, Philip S Crooke7, John Karijolich3, Thomas M Aune8.   

Abstract

Various sensors that detect double-stranded RNA, presumably of viral origin, exist in eukaryotic cells and induce IFN-responses. Ongoing IFN-responses have also been documented in a variety of human autoimmune diseases including relapsing-remitting multiple sclerosis (RRMS) but their origins remain obscure. We find increased IFN-responses in leukocytes in relapsing-remitting multiple sclerosis at distinct stages of disease. Moreover, endogenous RNAs isolated from blood cells of these same patients recapitulate this IFN-response if transfected into naïve cells. These endogenous RNAs are double-stranded RNAs, contain Alu and Line elements and are transcribed from leukocyte transcriptional enhancers. Thus, transcribed endogenous retrotransposon elements can co-opt pattern recognition sensors to induce IFN-responses in RRMS.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Alu retrotransposon; Double stranded RNA sensor; Interferons; Relapsing remitting multiple sclerosis

Year:  2019        PMID: 30826177      PMCID: PMC6513682          DOI: 10.1016/j.jaut.2019.02.003

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  69 in total

1.  Type I interferons and the quality of life of multiple sclerosis patients. Results from a clinical trial on interferon alfa-2a.

Authors:  M W Nortvedt; T Riise; K M Myhr; H I Nyland; B R Hanestad
Journal:  Mult Scler       Date:  1999-10       Impact factor: 6.312

Review 2.  Innate immune recognition: mechanisms and pathways.

Authors:  R Medzhitov; C Janeway
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

3.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 4.  Innate immune recognition.

Authors:  Charles A Janeway; Ruslan Medzhitov
Journal:  Annu Rev Immunol       Date:  2001-10-04       Impact factor: 28.527

Review 5.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

Review 6.  Interferons alpha and beta as immune regulators--a new look.

Authors:  C A Biron
Journal:  Immunity       Date:  2001-06       Impact factor: 31.745

Review 7.  The La protein.

Authors:  Sandra L Wolin; Tommy Cedervall
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

8.  Repbase update: a database and an electronic journal of repetitive elements.

Authors:  J Jurka
Journal:  Trends Genet       Date:  2000-09       Impact factor: 11.639

9.  Interferon-alpha2a reduces MRI disease activity in relapsing-remitting multiple sclerosis. Norwegian Study Group on Interferon-alpha in Multiple Sclerosis.

Authors:  K M Myhr; T Riise; F E Green Lilleås; T G Beiske; E G Celius; A Edland; D Jensen; J P Larsen; R Nilsen; M W Nortvedt; A I Smievoll; C Vedeler; H I Nyland
Journal:  Neurology       Date:  1999-03-23       Impact factor: 9.910

Review 10.  Antiviral actions of interferons.

Authors:  C E Samuel
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

View more
  13 in total

1.  DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs.

Authors:  Shao-Bin Wang; Siddharth Narendran; Shuichiro Hirahara; Akhil Varshney; Felipe Pereira; Ivana Apicella; Meenakshi Ambati; Vidya L Ambati; Praveen Yerramothu; Kameshwari Ambati; Yosuke Nagasaka; Dionne Argyle; Peirong Huang; Kirstie L Baker; Kenneth M Marion; Kartik Gupta; Bo Liu; David R Hinton; Scott W Canna; Tamer Sallam; Srinivas R Sadda; Nagaraj Kerur; Bradley D Gelfand; Jayakrishna Ambati
Journal:  Sci Immunol       Date:  2021-12-03

2.  Adenosine-to-Inosine RNA Editing of Alu Double-Stranded (ds)RNAs Is Markedly Decreased in Multiple Sclerosis and Unedited Alu dsRNAs Are Potent Activators of Proinflammatory Transcriptional Responses.

Authors:  John T Tossberg; Rachel M Heinrich; Virginia M Farley; Philip S Crooke; Thomas M Aune
Journal:  J Immunol       Date:  2020-10-12       Impact factor: 5.422

3.  Cutting Edge: Reduced Adenosine-to-Inosine Editing of Endogenous Alu RNAs in Severe COVID-19 Disease.

Authors:  Philip S Crooke; John T Tossberg; Krislyn P Porter; Thomas M Aune
Journal:  J Immunol       Date:  2021-03-29       Impact factor: 5.422

Review 4.  Epigenomic and transcriptomic analysis of chronic inflammatory diseases.

Authors:  Sabrina Ka Man Tam; Danny Chi Yeu Leung
Journal:  Genes Genomics       Date:  2021-02-27       Impact factor: 1.839

5.  Recognition of non-CpG repeats in Alu and ribosomal RNAs by the Z-RNA binding domain of ADAR1 induces A-Z junctions.

Authors:  Parker J Nichols; Shaun Bevers; Morkos Henen; Jeffrey S Kieft; Quentin Vicens; Beat Vögeli
Journal:  Nat Commun       Date:  2021-02-04       Impact factor: 14.919

6.  Reduced A-to-I editing of endogenous Alu RNAs in lung after SARS-CoV-2 infection.

Authors:  Philip S Crooke; John T Tossberg; Krislyn P Porter; Thomas M Aune
Journal:  Curr Res Immunol       Date:  2021-04-30

7.  Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.

Authors:  Nikolaos I Vlachogiannis; Aikaterini Gatsiou; Domenico Alessandro Silvestris; Kimon Stamatelopoulos; Maria G Tektonidou; Angela Gallo; Petros P Sfikakis; Konstantinos Stellos
Journal:  J Autoimmun       Date:  2019-09-05       Impact factor: 7.094

Review 8.  A potential new mechanism for pregnancy loss: considering the role of LINE-1 retrotransposons in early spontaneous miscarriage.

Authors:  Chao Lou; John L Goodier; Rong Qiang
Journal:  Reprod Biol Endocrinol       Date:  2020-01-21       Impact factor: 5.211

9.  A simplified method to produce mRNAs and functional proteins from synthetic double-stranded DNA templates.

Authors:  John T Tossberg; Tashawna M Esmond; Thomas M Aune
Journal:  Biotechniques       Date:  2020-08-20       Impact factor: 1.993

10.  Alu complementary DNA is enriched in atrophic macular degeneration and triggers retinal pigmented epithelium toxicity via cytosolic innate immunity.

Authors:  Shinichi Fukuda; Siddharth Narendran; Akhil Varshney; Yosuke Nagasaka; Shao-Bin Wang; Kameshwari Ambati; Ivana Apicella; Felipe Pereira; Benjamin J Fowler; Tetsuhiro Yasuma; Shuichiro Hirahara; Reo Yasuma; Peirong Huang; Praveen Yerramothu; Ryan D Makin; Mo Wang; Kirstie L Baker; Kenneth M Marion; Xiwen Huang; Elmira Baghdasaryan; Meenakshi Ambati; Vidya L Ambati; Daipayan Banerjee; Vera L Bonilha; Genrich V Tolstonog; Ulrike Held; Yuichiro Ogura; Hiroko Terasaki; Tetsuro Oshika; Deepak Bhattarai; Kyung Bo Kim; Sanford H Feldman; J Ignacio Aguirre; David R Hinton; Nagaraj Kerur; Srinivas R Sadda; Gerald G Schumann; Bradley D Gelfand; Jayakrishna Ambati
Journal:  Sci Adv       Date:  2021-09-29       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.